Results 151 to 160 of about 8,073 (209)

PDE5 inhibitors promote recovery of peripheral neuropathy in diabetic mice.

Neural Regen Res, 2017
Wang L, Chopp M, Zhang ZG.
europepmc   +1 more source

The PDE5 inhibitor vardenafil enhances glutamatergic transmission through amyloid-beta and cellular prion protein. [PDF]

Neurotherapeutics
Kafi MAA, Passalacqua M, Villa V, Thellung S, Corsaro A, Grimaldi R, Spatola E, Florio T, Baldelli P, Ricciarelli R.   +9 more
europepmc   +1 more source

Erectile dysfunction A clinical overview with perspectives from African settings. [PDF]

Can Urol Assoc J
Nhungo CJ, Mocha GE, Mushi FA, Mkony CA.
europepmc   +1 more source

Failure of PDE5 Inhibitor Use: A Case of Nonresponder? (CME)

The Journal of Sexual Medicine, 2010
openaire   +5 more sources

Structural basis of phosphodiesterase-5 conformational organization revealed by a PDE6/PDE5 chimera. [PDF]

J Biol Chem
Srivastava D, Singh S, Yu C, Boyd K, Artemyev NO.   +4 more
europepmc   +1 more source

Use of soluble guanylyl cyclase stimulators in heart failure therapy-a mode of action perspective. [PDF]

ESC Heart Fail
Ruschitzka F, Lukowski R, Corda S, Meier C, Sandner P.   +4 more
europepmc   +1 more source

Phosphodiesterase inhibitors for the management of lower urinary tract symptoms in men without benign prostatic hyperplasia: a systematic review. [PDF]

Transl Androl Urol
Bakhsh A, Rajih E, Barayan GA, Garah E, Khan I, Alrehaili Z, Alhejaili S, Almuways M, Aloufi T, Alnazawi H, Alharbi A, Farghal D, Badawi A.   +12 more
europepmc   +1 more source